Extra PET scan to check for silent kidney transplant rejection
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study tests whether an additional PET scan can help detect and guide treatment for “subclinical” (silent) rejection in people with kidney transplants. It may help doctors spot problems earlier and manage them more appropriately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Have a kidney transplant (you are a kidney recipient)
- Not be pregnant
- Not have polyomavirus nephropathy
- Not be “highly sensitized,” meaning you have very strong past immune antibodies to donors
- Be able to continue corticosteroids (steroids should not be stopped)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging scan (PET-CT) that might help doctors see if your new heart is being rejected without needing a biopsy. You will receive an injection of a slightly radioactive sugar substance, and the scan will show inflammation in the heart.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial tests a new type of PET scan to better see kidney tumors. It may help doctors understand the tumor better before biopsy or surgery.
This trial tests a special PET/CT scan using a new tracer to measure kidney function and predict how much kidney function will remain after surgery to remove part of a kidney. It may help doctors better plan surgery and manage your care.
This trial uses a special PET/CT scan to look at kidney scarring (fibrosis) in people with chronic kidney disease. It could help doctors monitor kidney damage without needing a biopsy.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
Hear when a new Kidney Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.